Folate Therapy Reduces Homocysteine Levels, Restenosis – NEJM Study
This article was originally published in The Tan Sheet
Executive Summary
Folate therapy's ability to lower homocysteine levels and reduce the risk of restenosis in patients who have undergone coronary angioplasty could make it a viable alternative to using stents, Swiss researchers suggest in the Nov. 29 New England Journal of Medicine
You may also be interested in...
Vitamin B Therapy In Stent Patients May Be Detrimental – NEJM Study
Vitamin B therapy does not appear to reduce arterial clogging in patients with coronary stents, and may actually increase clogging risk, a study published in the New England Journal of Medicine concludes
Vitamin B Therapy In Stent Patients May Be Detrimental – NEJM Study
Vitamin B therapy does not appear to reduce arterial clogging in patients with coronary stents, and may actually increase clogging risk, a study published in the New England Journal of Medicine concludes
Vitamin B Therapy In Stent Patients May Be Detrimental – NEJM Study
Vitamin B therapy does not appear to reduce arterial clogging in patients with coronary stents, and may actually increase clogging risk, a study published in the New England Journal of Medicine concludes